Richard G. Ghalie - Sep 29, 2023 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Chief Medical Officer
Signature
/s/ David M. Urso, as attorney in fact
Stock symbol
MEIP
Transactions as of
Sep 29, 2023
Transactions value $
$0
Form type
4
Date filed
10/12/2023, 07:38 PM
Previous filing
Jul 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +30K $0.00 30K Sep 29, 2023 Common Stock 30K $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024.